Pharmacy Department, Bellvitge University Hospital, University of Barcelona-IDIBELL, 08907 L'Hospitalet de Llobregat, Spain.
General Digestive Surgery Department, Bellvitge University Hospital, University of Barcelona-IDIBELL, 08907 L'Hospitalet de Llobregat, Spain.
Nutrients. 2023 Dec 21;16(1):40. doi: 10.3390/nu16010040.
(Background) Esophagectomy (EPG) presents high morbidity and mortality. Omega-3 fatty acids (ω-3FA) are a pharmaconutrient with benefits for postoperative morbidity. Studies of ω-3FA administered parenterally after esophagectomy are scarce. This study proposes to investigate the effect of combining fish oil lipid emulsions (LE) administered parenterally with enteral nutrition support. (Methods) Randomization was 1:1:1 in three groups: Group A received a LE mixture of 0.4 g/kg/day of fish oil and 0.4 g/kg/day of LCT/MCT 50:50, Group B received 0.8 g/kg/day of fish oil LE, and Group C received 0.8 g/kg/day of LCT/MCT 50:50. Variables were measured at recruitment time and day +1, +3, and +5. Inflammatory variables studied were Interlukin-6, C-reactive protein (CRP), tumoral necrosis factor-α (TNF-α), IL-10, IL-8 and CD25s. Safety, nutritional parameters and complications were analyzed. (Results) Administration of ω-3LE in the immediate postoperative period did not modulate the earlier inflammatory response. Statistically significant differences were found in IL-6 and CRP overall temporal evolution but were not found when studying the type of LE administered or in patients needing critical care. Administration of ω-3 resulted in safe and improved hypertriglyceridemia, depending on the dose. (Conclusions) ω-3FA has no impact on the early inflammatory postoperative response assessed for a short period but was safe. More studies for longer periods are needed.
(背景)食管切除术(EPG)具有较高的发病率和死亡率。ω-3 脂肪酸(ω-3FA)是一种具有术后发病率益处的药物营养素。关于术后给予ω-3FA 进行肠外治疗的研究很少。本研究旨在探讨联合给予鱼油脂质乳剂(LE)和肠内营养支持的效果。
(方法)随机分为三组,比例为 1:1:1:A 组给予 0.4 g/kg/天的鱼油和 0.4 g/kg/天的 LCT/MCT 50:50 的 LE 混合物,B 组给予 0.8 g/kg/天的鱼油 LE,C 组给予 0.8 g/kg/天的 LCT/MCT 50:50。在招募时和术后第 1、3、5 天测量变量。研究的炎症变量包括白细胞介素-6、C 反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、IL-10、IL-8 和 CD25s。分析安全性、营养参数和并发症。
(结果)在术后早期给予ω-3LE 并没有调节早期炎症反应。在总体时间演变中,IL-6 和 CRP 存在统计学上的显著差异,但在研究给予的 LE 类型或在需要重症监护的患者中没有发现差异。ω-3 的给予是安全的,并改善了高甘油三酯血症,这取决于剂量。
(结论)ω-3FA 对短期内评估的术后早期炎症反应没有影响,但安全。需要进行更长时间的更多研究。